
There has been an increase in the number of people with autoimmune diseases. Here’s what you should know about them.
There has been an increase in the number of people with autoimmune diseases. Here’s what you should know about them.
Autoimmune patients suffer a variety of comorbidities and often require extra care-here’s how the costs of that care can be reduced.
There has been an increase in the number of people with autoimmune diseases. Here’s what you should know about them.
Managing psoriasis can be difficult for a variety of reasons. Here’s a look at the top six challenges that experts identified.
Individuals with immune-mediated diseases, such as psoriasis, are at higher risk for having other immune-mediated diseases. Here’s how psoriasis can lead to other conditions, and the associated costs.
PBMs are in a unique position to leverage three critical tools to protect patients from unnecessary healthcare costs.
Health systems realize that telehealth can help them achieve a wide range of objectives, from care coordination to readmission avoidance and market share expansion.
This might be the year when it becomes clear, perhaps painfully so, whether or not biosimilars can deliver on cost savings expectations.
Allegheny Health Network’s Susan Manzi, MD, MPH, discusses the healthcare needs of patients with lupus and other autoimmune disorders.
New drugs for RA, psoriasis, type 1 diabetes and Crohn’s disease-some recently approved and others coming down the pipeline-could have an impact on the industry.
Find out about the latest treatment and drug pipeline developments
Here’s how one non-profit health plan harnessed the power of medical and pharmacy data to rein in drug costs.